Facility will put high-quality development and manufacturing for short half-life theranostic products within reach
MESA, AZ (October 21, 2024) — Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced that it has signed a lease and committed to build a new manufacturing facility in Mesa, Arizona. Once operational in mid-2026, the 53,000-square-foot facility will create 50 new skilled jobs.
The theranostic market currently faces a shortage of high-quality development and manufacturing space capable of meeting the volume needs of radiopharmaceutical treatments used in late-stage clinical trials, as well as those in the development pipeline that will soon receive regulatory approvals. Nucleus’ new space will help fulfill both of those needs, allowing its partners to produce crucial theranostics across the country. Nucleus will also build a new facility in Philadelphia, PA for a total of more than 100,000-square-feet of capacity between the two new sites. Once operational, the sites will allow Nucleus to more fully realize its commitment to a nationwide network capable of serving the ever-growing demand for theranostics across the U.S. ahead of the Rochester, MN site that will come online in early 2025.
“To reach their full potential as treatments for millions of patients with limited options, theranostic radiopharmaceuticals must be available close to those who need them,” said Nucleus RadioPharma CEO Charles S. Conroy. “Our expansion will significantly improve patient access to these life-saving treatments and expedite clinical trials, potentially reducing time-to-market for new therapies by up to 30%.”
“Nucleus RadioPharma’s new manufacturing facility highlights Arizona’s thriving bioscience industry that’s developing cutting-edge innovations to improve people’s lives,” said Sandra Watson, President and CEO of the Arizona Commerce Authority. “With this new facility, Nucleus RadioPharma strengthens Arizona’s bioscience leadership while developing breakthrough treatments for patients. We’re grateful to Nucleus RadioPharma for their commitment to Arizona.”
“We’re excited to welcome Nucleus RadioPharma’s new facility to Mesa,” said Mesa Mayor John Giles. “Their investment brings dozens of well-paying jobs to our city, boosting our local economy and enhancing our reputation as a hub for innovation. This expansion opens new doors for our local workforce and underscores Mesa’s role in supporting cutting-edge technology development. I’m confident this partnership will have long-lasting benefits for our community as well as patients across the nation.”
“Cancer has impacted countless families, including mine, so today’s announcement resonates deeply with me,” said Mesa Councilmember Scott Somers. “Nucleus RadioPharma’s presence in Mesa isn’t just about economic growth—it’s about hope. This facility will create advanced manufacturing jobs and ensure the steady supply of life-saving medications to help more people fight and overcome this disease.”
Media Contacts
Patrick Schmidt, Consort Partners on behalf of Nucleus RadioPharma, nucleusrad@consortpartners.com
Alyssa Tufts, Arizona Commerce Authority, alyssat@azcommerce.com
Kim Lofgreen, City of Mesa, kim.lofgreen@mesaaz.gov
About Nucleus RadioPharma
Nucleus RadioPharma is an innovative CDMO in the radiopharmaceutical industry, dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, the company provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Nucleus RadioPharma’s technology platforms are at the forefront of radiopharmaceutical research, designed to advance new therapies through clinical trials to commercialization. Recognized for its flexible approach, the company offers multiple onboarding points to accommodate innovators at various stages of their product lifecycle. Backed by Eclipse, GE HealthCare, AstraZeneca, Mayo Clinic, Echo Global, Fox Chase Cancer Center, Granger Management, Mercy Health, and University of Missouri, Nucleus RadioPharma stands well-supported by leading institutions and organizations committed to advancing healthcare through innovative solutions. Please visit nucleusrad.com and follow us on LinkedIn for more information.
About the Arizona Commerce Authority
The Arizona Commerce Authority (ACA) is the state’s leading economic development organization with a streamlined mission to grow and strengthen Arizona’s economy. The ACA uses a three-pronged approach to advance the overall economy: attract, expand, create – attract out-of-state companies to establish operations in Arizona; work with existing companies to expand their business in Arizona and beyond; and help entrepreneurs create new Arizona businesses in targeted industries. For more information, please visit azcommerce.com and follow the ACA on Twitter @azcommerce.
About the City of Mesa
With a population of more than 517,000, Mesa, Arizona is the 36th largest city in the United States and second largest in the Phoenix-Mesa metro area. Mesa encompasses 138 square miles inside the metro area, which has a population of 5 million people and is projected to grow to 5.2 million by 2028. Mesa is a vibrant city and a premier location for business development opportunities. Serving industry leaders such as Amazon, Apple, AT&T, Boeing, Bridgestone, Dexcom, Meta, Google, Gulfstream, Northrop Grumman, Virgin Galactic, and many more, Mesa is a smart location for intelligent companies. For more information, please visit SelectMesa.com.